Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis
Yaqian Tan(Guangzhou Medical University), Haipeng Zhang(Jinan University), Jialuo Mai(Sun Yat-sen University), Jun Hu(China University of Geosciences), Chuntao Li(Sun Yat-sen University), Mingshi Gao(Sun Yat-sen University), Jing Cai(Shandong University), Fan Xing(Sun Yat-sen University), Bingzheng Lu(Sun Yat-sen University), Kai Li(China University of Geosciences (Beijing)), Guangmei Yan(Sun Yat-sen University), Yuan Lin(Sun Yat-sen University), Wei Yin, Songmin He(Cornell University), Shoufang Gong(Regenex Pharmaceuticals (China)), Xiaohong Tan(Beijing Proteome Research Center), Wenbo Zhu(Sun Yat-sen University), Ling Lu(Qingdao National Laboratory for Marine Science and Technology), Xiao Xiao(Guangdong Academy of Medical Sciences), Li Guo(Nanjing University of Posts and Telecommunications), Xingwen Su(Sun Yat-sen University), Jiayu Gu(Sun Yat-sen University), Pengxin Qiu, Jiankai Liang(Sun Yat-sen University)
Cited by 24
Related Papers
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers
|Proceedings of the National Academy of Sciences|2014|167
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
|Molecular Cancer|2011|139